Table 3 aGVHD and cGVHD manifestations... | American Society of Hematology

Table 3

aGVHD and cGVHD manifestations

SPN	RD/URD	CD34 cell dose/kg, × 10⁶	Full donor chimerism*	aGVHD onset	aGVHD grade	aGVHD organs involved	cGVHD onset	cGVHD severity	cGVHD organs involved	Days on prednisone
3431	RD	7.5	D28				D322	Moderate	Mouth, liver, fasciitis	241
3489	RD	10.4	D90	D70	2	Skin	D350	Mild	Skin, liver	133
3567	RD	4.9	D180				D180	Moderate	Mouth, liver, joints	378
3723	URD	4.8	D28	D25	2	Skin	D146	Severe	Skin, gut, liver	Never stopped, death (562 days on steroids)
3879	RD	6.2	D90				D413	Moderate	Skin, fasciitis	Never stopped, death (425 days on steroids)
3934	RD	5.6	D28				D168	Moderate	Mouth, gut, skin	644
3969	RD	6.6	D180				D200	Mild	Skin, gut	471

SPN	RD/URD	CD34 cell dose/kg, × 10⁶	Full donor chimerism*	aGVHD onset	aGVHD grade	aGVHD organs involved	cGVHD onset	cGVHD severity	cGVHD organs involved	Days on prednisone
3431	RD	7.5	D28				D322	Moderate	Mouth, liver, fasciitis	241
3489	RD	10.4	D90	D70	2	Skin	D350	Mild	Skin, liver	133
3567	RD	4.9	D180				D180	Moderate	Mouth, liver, joints	378
3723	URD	4.8	D28	D25	2	Skin	D146	Severe	Skin, gut, liver	Never stopped, death (562 days on steroids)
3879	RD	6.2	D90				D413	Moderate	Skin, fasciitis	Never stopped, death (425 days on steroids)
3934	RD	5.6	D28				D168	Moderate	Mouth, gut, skin	644
3969	RD	6.6	D180				D200	Mild	Skin, gut	471

RD indicates matched related donor; URD, unrelated donor.

Peripheral blood CD3 > 95% first achieved.